KR20010079695A - 시클릭 프로사포신 유래 펩티드 및 그의 이용 - Google Patents
시클릭 프로사포신 유래 펩티드 및 그의 이용 Download PDFInfo
- Publication number
- KR20010079695A KR20010079695A KR1020017002478A KR20017002478A KR20010079695A KR 20010079695 A KR20010079695 A KR 20010079695A KR 1020017002478 A KR1020017002478 A KR 1020017002478A KR 20017002478 A KR20017002478 A KR 20017002478A KR 20010079695 A KR20010079695 A KR 20010079695A
- Authority
- KR
- South Korea
- Prior art keywords
- amino acid
- peptide
- acid
- hydrophobic amino
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9835998P | 1998-08-28 | 1998-08-28 | |
| US60/098,359 | 1998-08-28 | ||
| PCT/US1999/019378 WO2000012553A1 (fr) | 1998-08-28 | 1999-08-20 | Peptides cycliques derives de la prosaposine et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010079695A true KR20010079695A (ko) | 2001-08-22 |
Family
ID=22268937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020017002478A KR20010079695A (ko) | 1998-08-28 | 1999-08-20 | 시클릭 프로사포신 유래 펩티드 및 그의 이용 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1105420A1 (fr) |
| JP (2) | JP4528443B2 (fr) |
| KR (1) | KR20010079695A (fr) |
| CN (1) | CN1324367A (fr) |
| AU (1) | AU751034B2 (fr) |
| BR (1) | BR9913490A (fr) |
| CA (1) | CA2341810A1 (fr) |
| CZ (1) | CZ2001655A3 (fr) |
| HU (1) | HUP0103265A3 (fr) |
| IL (1) | IL141586A0 (fr) |
| PL (1) | PL204359B1 (fr) |
| WO (1) | WO2000012553A1 (fr) |
| ZA (1) | ZA200102489B (fr) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
| HUP0103265A3 (en) * | 1998-08-28 | 2002-09-30 | Myelos Corp San Diego | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use |
| AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
| IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
| CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
| WO2007127439A2 (fr) | 2006-04-28 | 2007-11-08 | Children's Hospital Medical Center | Propriétés fusiogènes de la saposine c et de protéines et peptides apparentés pour une application dans des systèmes de délivrance transmembranaire de médicaments |
| JP5253402B2 (ja) * | 2006-10-20 | 2013-07-31 | チルドレンズ ホスピタル メディカル センター | 自発的に形成する楕円体の単層リン脂質小胞 |
| CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
| BR112017022021B1 (pt) | 2015-04-23 | 2021-07-06 | The Procter & Gamble Company | Composição para tratamento dos cabelos |
| ES2893974T3 (es) | 2016-03-03 | 2022-02-10 | Procter & Gamble | Composición anticaspa en aerosol |
| WO2018075850A1 (fr) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Dosage de mousse destiné à distribuer un volume de dosage et une quantité de tensioactif souhaités par un consommateur dans un espace de formulation optimal |
| CN109843258A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 表示毛发调理有益效果的浓缩型洗发剂泡沫剂型 |
| CN109843383A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 用于在最佳制剂空间中递送消费者期望的剂量体积、表面活性剂量和头皮健康剂量的泡沫剂型 |
| WO2018075847A1 (fr) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Dosage de shampooing concentré de mousse désignant des avantages de volume des cheveux |
| WO2018075832A1 (fr) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Produits de shampooing compacts stables à faible viscosité et agent de réduction de viscosité |
| EP3528896A1 (fr) | 2016-10-21 | 2019-08-28 | The Procter & Gamble Company | Dosage de shampooing concentré de mousse pour fournir des bénéfices de soins capillaires |
| US20180110688A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated Shampoo Dosage of Foam for Providing Hair Care Benefits |
| US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
| US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
| US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
| EP3694482B1 (fr) | 2017-10-10 | 2022-04-13 | The Procter & Gamble Company | Composition nettoyante d'hygiène corporelle sans sulfates à faible teneur en sel inorganique |
| MX2020003318A (es) | 2017-10-10 | 2021-12-06 | Procter & Gamble | Composición de champú compacta con surfactantes aniónicos a base de aminoácidos y polímeros catiónicos. |
| EP3694479A1 (fr) | 2017-10-10 | 2020-08-19 | The Procter and Gamble Company | Méthode de traitement des cheveux ou de la peau avec une composition de soins personnels sous forme de mousse |
| US11116703B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
| WO2019126444A1 (fr) | 2017-12-20 | 2019-06-27 | The Procter & Gamble Company | Composition de shampooing transparent contenant des polymères de silicone |
| WO2020005309A1 (fr) | 2018-06-29 | 2020-01-02 | The Procter & Gamble Company | Composition antipelliculaire en aérosol à faible teneur en tensioactif |
| JP7410298B2 (ja) | 2019-12-06 | 2024-01-09 | ザ プロクター アンド ギャンブル カンパニー | 頭皮活性物質の付着を強化する硫酸塩を含まない組成物 |
| JP7481470B2 (ja) | 2020-02-27 | 2024-05-10 | ザ プロクター アンド ギャンブル カンパニー | 有効性及び美観が強化された硫黄含有フケ防止組成物 |
| EP4255375A1 (fr) | 2020-12-04 | 2023-10-11 | The Procter & Gamble Company | Compositions de soins capillaires comprenant des substances réduisant les mauvaises odeurs |
| US20220378684A1 (en) | 2021-05-14 | 2022-12-01 | The Procter & Gamble Company | Shampoo Compositions Containing a Sulfate-Free Surfactant System and Sclerotium Gum Thickener |
| US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| HUP0103265A3 (en) * | 1998-08-28 | 2002-09-30 | Myelos Corp San Diego | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use |
-
1999
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/fr not_active Application Discontinuation
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Application Discontinuation
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 CA CA002341810A patent/CA2341810A1/fr not_active Abandoned
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
- 1999-08-20 EP EP99943903A patent/EP1105420A1/fr not_active Withdrawn
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU5690599A (en) | 2000-03-21 |
| CA2341810A1 (fr) | 2000-03-09 |
| HUP0103265A2 (hu) | 2002-02-28 |
| BR9913490A (pt) | 2001-09-25 |
| PL346346A1 (en) | 2002-02-11 |
| HUP0103265A3 (en) | 2002-09-30 |
| AU751034B2 (en) | 2002-08-08 |
| CN1324367A (zh) | 2001-11-28 |
| JP2002523518A (ja) | 2002-07-30 |
| ZA200102489B (en) | 2002-06-04 |
| WO2000012553A1 (fr) | 2000-03-09 |
| EP1105420A1 (fr) | 2001-06-13 |
| IL141586A0 (en) | 2002-03-10 |
| JP2010150272A (ja) | 2010-07-08 |
| CZ2001655A3 (cs) | 2001-11-14 |
| PL204359B1 (pl) | 2010-01-29 |
| JP4528443B2 (ja) | 2010-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4528443B2 (ja) | 環状プロサポシン由来のペプチドおよびその使用 | |
| CA2058443C (fr) | Traitement de certains troubles par application de facteurs de croissance insulinoides et de leurs analogues | |
| DE69736712T2 (de) | Verfahren zur milderung von neuropatischen schmerz mit prosaposin verwandten peptiden | |
| US5703045A (en) | Treating disorders by application of insulin-like growth factors and analogs | |
| US6458357B1 (en) | Retro-inverso neurotrophic and analgesic peptides | |
| US6849602B1 (en) | Compositions for alleviating neuropathic pain with prosaposin receptor agonists | |
| EP0979238A1 (fr) | Procedes pour soulager les douleurs neuropathiques | |
| WO1998042746A2 (fr) | Peptides neurotrophiques de synthese derives de la saposine c | |
| WO1998042746A9 (fr) | Peptides neurotrophiques de synthese derives de la saposine c | |
| EP1183266A1 (fr) | Peptides retro inverses derives du facteur d'inhbition de la leucemie | |
| US7754690B2 (en) | Method of using retro inverso peptides derived from leukemia inhibitory factor | |
| MXPA01001966A (en) | Cyclic prosaposin-derived peptides and uses thereof | |
| US20020128193A1 (en) | Retro-inverso prosaposin-derived peptides and use thereof | |
| AU2002300005B2 (en) | Method of alleviating neuropathic pain | |
| AU4267297A (en) | Method of alleviating neuropathic pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |